Skip to main content
Top
Published in: Clinical Oral Investigations 6/2012

01-12-2012 | Original Article

Spin electron paramagnetic resonance of albumin for diagnosis of oral squamous cell carcinoma (OSCC)

Authors: Maximilian Moergel, Peer W. Kämmerer, Kerstin Schnurr, Marcus O. Klein, Bilal Al-Nawas

Published in: Clinical Oral Investigations | Issue 6/2012

Login to get access

Abstract

Objectives

Albumin has a known capability to modulate free serum concentrations of proteins produced by tumour cells. The technique of spin probe labelling of albumin followed by electron paramagnetic resonance (EPR) spectroscopy may allow identification of these structural and functional changes, which regularly occur as consequence of binding tumour metabolites as ligands. The aim of the present study was a proof of principle evaluation of EPR-analysis of peripheral blood samples as possible predictor for oral squamous cell carcinoma (OSCC).

Material and methods

The present study is designed as gender-matched cohort. EPR was tested after retrieval of peripheral blood samples. The study group is represented by 32 patients with OSCC, and the control group consisted of 30 healthy patients.

Results

Overall analysis exhibited a diagnostic sensitivity of 72% (23/32 OSCC group) and a specificity of 80% (24/30 control group). Subgroup analysis revealed ten patients with elevated leukocytes (>10,000/μl; n = 9 [OSCC group] and n = 1 [control group]). After exclusion of patients with elevated white blood cell count, sensitivity considerably increased to 87% and specificity to 83%.

Conclusion

EPR analysis of peripheral blood samples might be appropriate to support the clinician in primary and follow-up diagnosis of potential tumours such as OSCC. Unfortunately, subgroup analysis characterises the method vulnerable to inflammation.

Clinical relevance

Nevertheless, our preliminary results are intriguing, as diagnosis of OSCC appears possible by simple peripheral blood examination. Thus, further appraisal of this novel method with inclusion of different tumour entities, systemic conditions and inflammation in a larger study population appears highly valuable.
Literature
1.
go back to reference Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. IARC Press, Lyon Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. IARC Press, Lyon
2.
go back to reference Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (2003) The case for early detection. Nat Rev Cancer 3:243–252PubMedCrossRef Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (2003) The case for early detection. Nat Rev Cancer 3:243–252PubMedCrossRef
3.
go back to reference Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W (2011) Effectiveness of autofluorescence to identify suspicious oral lesions — a prospective, blinded clinical trial. Clin Oral Investig 15:975–982 Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W (2011) Effectiveness of autofluorescence to identify suspicious oral lesions — a prospective, blinded clinical trial. Clin Oral Investig 15:975–982
4.
go back to reference Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, Liotta LA (2004) Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 1022:295–305PubMedCrossRef Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, Liotta LA (2004) Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 1022:295–305PubMedCrossRef
5.
go back to reference Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, Damico LA (2002) Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 277:35035–35043PubMedCrossRef Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, Damico LA (2002) Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 277:35035–35043PubMedCrossRef
6.
go back to reference Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, Veenstra TD, Conrads TP, Goldsmith P, Fishman D, Petricoin EF 3rd, Liotta LA (2005) Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51:1933–1945PubMedCrossRef Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, Veenstra TD, Conrads TP, Goldsmith P, Fishman D, Petricoin EF 3rd, Liotta LA (2005) Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51:1933–1945PubMedCrossRef
7.
go back to reference Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, Liotta LA (2003) Biomarker amplification by serum carrier protein binding. Dis Markers 10:1–10 Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, Liotta LA (2003) Biomarker amplification by serum carrier protein binding. Dis Markers 10:1–10
8.
go back to reference Oettl K, Stauber RE (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151:580–590PubMedCrossRef Oettl K, Stauber RE (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151:580–590PubMedCrossRef
9.
go back to reference Gurachevsky A, Kazmierczak SC, Jorres A, Muravsky V (2008) Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin Chem Lab Med 46:1203–1210PubMedCrossRef Gurachevsky A, Kazmierczak SC, Jorres A, Muravsky V (2008) Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin Chem Lab Med 46:1203–1210PubMedCrossRef
10.
go back to reference Gelos M, Hinderberger D, Welsing E, Belting J, Schnurr K, Mann B (2010) Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis 25:119–127PubMedCrossRef Gelos M, Hinderberger D, Welsing E, Belting J, Schnurr K, Mann B (2010) Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis 25:119–127PubMedCrossRef
11.
go back to reference Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, Muravsky V, Williams R, Matthes G, Davies NA (2009) Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 50:555–564PubMedCrossRef Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, Muravsky V, Williams R, Matthes G, Davies NA (2009) Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 50:555–564PubMedCrossRef
12.
go back to reference Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V (2006) Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin Chem 52:2129–2134PubMedCrossRef Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V (2006) Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin Chem 52:2129–2134PubMedCrossRef
13.
go back to reference Berliner LJ (1976) Spin labeling: theory and applications. Academic, New York Berliner LJ (1976) Spin labeling: theory and applications. Academic, New York
14.
go back to reference Curry S, Mandelkow H, Brick P, Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5:827–835PubMedCrossRef Curry S, Mandelkow H, Brick P, Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5:827–835PubMedCrossRef
15.
go back to reference Peters T (1996) All about albumin: biochemistry, genetics, and medical applications. Academic, San Diego, CA Peters T (1996) All about albumin: biochemistry, genetics, and medical applications. Academic, San Diego, CA
16.
go back to reference Salikhov I, Walczak T, Lesniewski P, Khan N, Iwasaki A, Comi R (2005) EPR spectrometer for clinical applications. Magn Reson Med 54:1317–1320PubMedCrossRef Salikhov I, Walczak T, Lesniewski P, Khan N, Iwasaki A, Comi R (2005) EPR spectrometer for clinical applications. Magn Reson Med 54:1317–1320PubMedCrossRef
17.
go back to reference Afanas’eva AN, Evtushenko VA (2004) Conformation changes in albumin molecule as a marker of dissemination of the tumor process. Bull Exp Biol Med 138:177–178PubMed Afanas’eva AN, Evtushenko VA (2004) Conformation changes in albumin molecule as a marker of dissemination of the tumor process. Bull Exp Biol Med 138:177–178PubMed
Metadata
Title
Spin electron paramagnetic resonance of albumin for diagnosis of oral squamous cell carcinoma (OSCC)
Authors
Maximilian Moergel
Peer W. Kämmerer
Kerstin Schnurr
Marcus O. Klein
Bilal Al-Nawas
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Clinical Oral Investigations / Issue 6/2012
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-011-0655-3

Other articles of this Issue 6/2012

Clinical Oral Investigations 6/2012 Go to the issue